A prospective, multicentre, observational real-world evidence study to evaluate prescribing patterns, clinical outcomes and safety of Tedizolid 200 mg in patients with diabetic foot infection.
VISIT 1 (D0): BASELINE VISIT
Assessment: Evaluate the patient's skin condition.
Questionnaire: Complete two sets of pretreatment questionnaires (Doctor & Patient)